Radient Technologies (Radient Technologies) Capex-to-Operating-Income : 0.00 (As of Dec. 2022)

View and export this data going back to 2016. Start your Free Trial

What is Radient Technologies Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Radient Technologies's Capital Expenditure for the three months ended in Dec. 2022 was $0.00 Mil. Its Operating Income for the three months ended in Dec. 2022 was $-0.23 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.

Radient Technologies Capex-to-Operating-Income Historical Data

The historical data trend for Radient Technologies's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radient Technologies Capex-to-Operating-Income Chart

Radient Technologies Annual Data

Trend

Dec13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Capex-to-Operating-Income

Get a 7-Day Free Trial

Radient Technologies Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Capex-to-Operating-Income	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Radient Technologies's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, Radient Technologies's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Radient Technologies's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Radient Technologies's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Radient Technologies's Capex-to-Operating-Income falls into.

Radient Technologies Capex-to-Operating-Income Calculation

Radient Technologies's Capex-to-Operating-Income for the fiscal year that ended in Mar. 2022 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-1.246)	/	-5.221
	=	N/A

Radient Technologies's Capex-to-Operating-Income for the quarter that ended in Dec. 2022 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (0)	/	-0.23
	=	N/A

Radient Technologies (OTCPK:RDDTF) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Radient Technologies Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Radient Technologies's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Radient Technologies (Radient Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Radient Technologies Inc (OTCPK:RDDTF) » Definitions » Capex-to-Operating-Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

4035 101 St. NW, Edmonton, AB, CAN, T6E 0A4

Website

https://www.radientinc.com

Radient Technologies Inc is a Canadian company engaged in manufacturing cannabis derivatives, formulations, and products. It has developed its extraction process, Microwave Assisted Processing (MAP), which is used for producing a consistent product at industrial-scale quantities. It provides its customers and partners with white-label extracts, formulations, and finished products that contain a broad spectrum of cannabinoid and terpene profiles. While it operates in Canada and is building an additional facility in Germany. It operates in a single segment namely the production and sale of cannabis-related retail products.